AAREY DRUGS & PHARM LTD DCF Valuation

AAREYDRUGS · Healthcare · Current price ₹92.52

Full stock page
DocStoX fair value
₹48
high confidence
Intrinsic-value estimate
₹46
3% ROE fading to 13% over ~3 yrs, on ₹53 book
Current price
₹93
Economic moat
None
Low uncertainty
5Y profit growth
-10.7%
Model it yourself — DCF Calculator
Opens pre-filled with AAREY DRUGS & PHARM LTD's latest numbers.

AAREY DRUGS & PHARM LTD intrinsic-value estimate

Our intrinsic-value model estimates AAREY DRUGS & PHARM LTD is worth ₹46 per share, based on 3% ROE fading to 13% over ~3 yrs, on ₹53 book. Rather than a raw DCF — which is highly sensitive to fragile cash-flow forecasts — we use a residual-income (excess-return) model: a company is worth its book value plus the present value of the returns it earns ABOVE its cost of equity. A none economic moat sets how long that edge is assumed to last.

Try your own assumptions

Prefer a classic discounted-cash-flow view? Open the DCF calculator below — it pre-fills AAREY DRUGS & PHARM LTD's real free cash flow, net debt and share count so you can model your own growth and discount-rate scenario in seconds.

More on AAREY DRUGS & PHARM LTD

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.